OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources

Medications After Allogeneic Transplant

Last Modified: November 6, 2005

Question

Dear OncoLink "Ask The Experts,"
I am post-transplant (non- related donor). I was just discharged with my meds. One medication is Zyvox. I don't know what this is for. I have no infections and my WBC (white blood cell count) is adequate. I looked it up online and it says something about myelosupression. What is that? Does myelosupression mean it might hurt my new bone marrow?

Answer

Vicki Sherry, MSN, CRNP, Advanced Practice Oncology Nurse, responds:

You have touched on a few issues. The first is Zyvox. This is a medication used to treat certain infections that are, unfortunately, commonly seen in hospitalized patients. These include Methicillin-resistant Staph Aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE). Even though the infection may not be "active" and you may not feel sick, the bacterial infection often needs to be treated for as long as 6-8 weeks in order for it to be completely eliminated from the body.

Now, regarding the piece you read about myelosuppression: Zyvox can cause myelosuppression (as can many other medications -- it is a potential side effect of them). Myelosuppression is a "slowing down" of bone marrow activity resulting in low blood counts. The bone marrow, which is responsible for making white & red blood cells and platelets, slows its production of these cells. Myelosuppression also occurs after receiving chemotherapy, when the bone marrow cells are destroyed by the chemo and the marrow cannot "catch up" by making new cells quickly enough, so you have a period of low blood counts. The good news is, if there is myelosuppression caused by a medication, it is reversible, and the blood counts typically return to normal after the drug is stopped. This side effect would not harm your new bone marrow, either.

OncoLink I wish u knew...

Dr. Vapiwala discusses the decisions to screen for breast and prostate cancers. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS